Petra Pharma Corp — Form D/A

Petra Pharma Corp of NEW YORK, NY, a company, filed a Form D amendment with the SEC on 2020-03-31. The offering totals $27.5M, of which $27.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (35)

Showing 25 of 35 people.

NameRoleLocation
Barbara Johnston DaltonDirectorNew York, NY
M. Johnston ErwinDirectorNew York, NY
Jenna Johnston FogerDirectorNew York, NY
Steve GillisDirectorNew York, NY
THONG LEDirectorSeattle, WA
Brian Johnston O'CallaghanDirectorNew York, NY
Paul Johnston SekhriDirectorNew York, NY
David Johnston McElligottExecutive OfficerNew York, NY
Brian Johnston O'CallaghanExecutive OfficerNew York, NY
David Johnston RenasExecutive OfficerNew York, NY
Albert Johnston YuExecutive OfficerNew York, NY
THONG LEPromoterSeattle, WA
David Johnston McElligottPromoterNew York, NY
Lindsay Johnston RaylePromoterNew York, NY
David Johnston SchubertPromoterNew York, NY
Steve GillisRelated PersonNew York, NY
Brian O'CallaghanRelated PersonNew York, NY
THONG LEExecutive OfficerSeattle, WA
THONG LERelated PersonSeattle, WA
LINDSAY RAYLERelated PersonNew York, NY
Asish XavierDirectorSouth San Francisco, CA
Paul SekhriRelated PersonNew York, NY
M. Johnston ErwinRelated PersonNew York, NY
David SchubertRelated PersonNew York, NY
Albert Johnston YuPromoterNew York, NY

Other filings by this issuer (7)

FiledFormOfferingSold
2019-10-21D/A$23.0M$20.0M
2019-08-01D/A$17.0M$17.0M
2019-04-26D/A$13.3M$13.3M
2018-09-13D$10.0M$10.0M
2018-01-22D/A$48.3M$31.2M
2017-01-04D/A$48.3M$21.2M
2016-01-06D$10.4M$10.0M

More